In the study by Zhang et al., a high concentration (10 μM) of PLX7904 did not activate MEK-ERK signalling in A431 epidermoid carcinoma, SKBR3 breast cancer, and B9 cutaneous squamous cell carcinoma cell lines, all of which express wildtype BRAF17. This evidence concerns the gene MAP2K7 and squamous cell carcinoma.